Gold slips from record highs after strong economic data; set for weekly rise
Asian stock markets are celebrating the latest headlines that the first phase of a potential trade deal agreement is planned to be signed by mid-November 2019. Yet the trend does not support EU equities as the US is expected to announce tariffs of $7.5 billion on EU goods by mid-October following WTO ruling on Airbus subsidies while rumors of potential tariffs on Swiss pharma are emerging.
Asian investors have turned to US-China trade negotiations that would force China to purchase up to $40 - $50 billion of US agricultural products per year, in exchange for a deferral of US tariffs on $250 billion of Chinese goods. Yet trade progresses remain limited since the coming phases focusing on structural issues such as forced technology transfer, intellectual property protection and government subsidies are likely to mute current optimistic views as December tariffs on $156 billion of Chinese goods are still on the pipeline. Despite short-sight optimism, the release of September exports and imports at -3.20% (prior: -1%) and -8.50% (prior: -5.60%), drops to respectively 7-month and 4-month low amid sluggish domestic demand should force Chinese authorities to strengthen monetary policy easing measures in order to maintain current growth target within the lower end of current 6% - 6.50% target band. On the same line, EU lawmakers are willing to take countermeasures against US duties on aerospace, whiskey and cheese due in the coming days as further tariffs on EU cars could well come into force in November, paving the way towards escalating trade tensions. In addition, the Swiss pharmaceutical industry could face similar sanctions with an introduction of tariffs on Swiss drugs exports in the US, the second largest market after the EU. The latter would not only harm the competitiveness and margins of the Swiss pharmaceutical industry (e.g. generics and biosimilars), but would also have a considerable impact on the country, as the industry represents about one-fifth of GDP contribution.
USD/CNY is currently trading at 7.0743, slightly above current fixing at 7.0725
"Disclaimer: While every effort has been made to ensure that the datat quoted and used for the research behind this document is reliable, there is no guarantee that it is correct, and Swissquote Bank and its subsidiaries can accept no liability whatsoever in respect of any errors or omissions, or regarding the accuracy, completeness or reliability of the information contained herein. This document does not constitute a recommendation o sell and/or buy any financial products and is not to be considered as a solicitation and/or an offer to enter into any transaction. This document is a piece of economic research and is not intended to constitute investment advice, nor to solicit dealing in securities or in any other kind of investment.
Although every investment involves some degree of risk, the risk of loss trading off-exchange forex contracts can be substantial. Therefore if you are considering trading in this market, you should be aware of the risks associated with this product so you can make informed decisions prior to investing. The material presented here in not to be construed as trading advice or strategy. Swissquote Bank makes a strong effort to use reliable, expansive information, but we make no representation that it is accurate or complete. In addition, we have no obligation to notify you when opinions or data in this material change. Any prices stated in this report are for information purposes only and do not represent valuations for individual securities or other instruments."